All Stories

  1. Biomarkers of plasticity and recovery after stroke: Insights from the PRACTISE trial

    Article • Clinical Neurology and Neurosurgery, September 2026, Elsevier

    Professor Anders Olof Larsson

  2. Response to the letter to the editor: From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting

    Article • Clinical Biochemistry, August 2026, Elsevier

    Professor Anders Olof Larsson

  3. Impact of Regional Hepatic Immunosuppression With Budesonide on Bacterial Elimination in Porcine Abdominal Sepsis

    Article • Acta Anaesthesiologica Scandinavica, July 2026, Wiley

    Professor Anders Olof Larsson

  4. Evaluating Patient Medians for Laboratory Quality Control Using Long-Term Carbamazepine Monitoring Data

    Article • The Journal of Applied Laboratory Medicine, July 2026, Oxford University Press (OUP)

    Professor Anders Olof Larsson

  5. Analysis of albumin-to-creatinine ratio on automated analysers using a microsampling card (Capitainer DIP70 card) for the collection of urine

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), June 2026, De Gruyter

    Professor Anders Olof Larsson

  6. Long-Term Stability of Cyclosporine Blood Concentrations Assessed by Patient-Based Percentiles over 20 Years

    Article • Pharmaceutics, June 2026, MDPI AG

    Professor Anders Olof Larsson

  7. Calprotectin as a Diagnostic Marker for Lower Respiratory Tract Infection and Sepsis in the Emergency Department

    Article • Open Forum Infectious Diseases, June 2026, Oxford University Press (OUP)

    Professor Anders Olof Larsson

  8. Response to the letter to the editor by Drs Burmeister and Zazay regarding “NT-proBNP and its correlation with left ventricular ejection fraction and heart failure: The DEMONSTRATE database

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, May 2026, SAGE Publications

    Professor Anders Olof Larsson

  9. Performance evaluation of an avian antibody-based particle-enhanced turbidimetric assay for free kappa and lambda light chains

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, May 2026, Taylor & Francis

    Professor Anders Olof Larsson

  10. Trend-based quality assurance of binary urinary antigen tests

    Article • PLOS One, April 2026, PLOS

    Professor Anders Olof Larsson

  11. Unbound cloxacillin plasma concentrations in relation to toxicity and renal function: protocol for a prospective, observational clinical trial in a real-world Staphylococcus aureus bacteraemia population

    Article • BMJ Open, April 2026, BMJ

    Professor Anders Olof Larsson

  12. The Association between Serum Endostatin, Kidney Disease Progression, and Mortality in Patients with Chronic Kidney Disease in the Salford Kidney Study

    Article • Pulse, March 2026, Karger Publishers

    Axel Carlsson, Professor Anders Olof Larsson

  13. Disease-Causing Mechanisms and Therapeutic Targets in Infectious Diseases: Implications for Clinical Management and Public Health

    Article • Biomedicines, March 2026, MDPI AG

    Professor Anders Olof Larsson

  14. Inter-laboratory variability in vancomycin measurement in an external quality assessment scheme 2016–2025

    Article • Clinical Biochemistry, March 2026, Elsevier

    Professor Anders Olof Larsson

  15. Neutrophil gelatinase-associated lipocalin (NGAL) is a poor diagnostic marker for sepsis in the ICU – an observational multicentre study

    Article • February 2026, openRxiv

    Professor Anders Olof Larsson

  16. Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 15-Year Retrospective Study

    Article • Pharmaceutics, February 2026, MDPI AG

    Professor Anders Olof Larsson

  17. Longitudinal Trends and Analytical Consistency of Folate and Vitamin B12 Biomarkers: Two Decades of Population-Based Data and Diagnostic Implications

    Article • Biomedicines, January 2026, MDPI AG

    Professor Anders Olof Larsson

  18. Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals

    Article • Biomedicines, January 2026, MDPI AG

    Professor Anders Olof Larsson

  19. Patient Median-Based Quality Control in Lamotrigine Therapeutic Drug Monitoring: A 17-Year Retrospective Study

    Article • December 2025, MDPI AG

    Professor Anders Olof Larsson

  20. Response to: Shift happens: The utility of external quality assessment data in evaluating folate lot changes. doi.org/10.1515/cclm-2025-1569

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), December 2025, De Gruyter

    Professor Anders Olof Larsson

  21. Long term monitoring of serum valproate assays using patient median values show stable test results over a period of more than 20 years

    Article • Pharmacological Research - Reports, December 2025, Elsevier

    Professor Anders Olof Larsson

  22. NT-proBNP and its correlation to left ventricular ejection fraction and heart failure – The DEMONSTRATE database

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, November 2025, SAGE Publications

    Professor Anders Olof Larsson

  23. Mapping Interactions Between Cytokines, Chemokines, Growth Factors, and Conventional Biomarkers in COVID-19 ICU-Patients

    Article • International Journal of Molecular Sciences, November 2025, MDPI AG

    Professor Anders Olof Larsson

  24. Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients

    Article • BMC Oral Health, November 2025, Springer Science + Business Media

    Professor Anders Olof Larsson

  25. Liquid biomarkers associate with TGF-β Type I receptor and hypoxia in kidney cancer

    Article • Signal Transduction and Targeted Therapy, September 2025, Springer Science + Business Media

    Professor Anders Olof Larsson

  26. Age- and sex-specific reference values for FIB-4 derived from the Nordic Reference Interval Project (NORIP)

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, August 2025, Taylor & Francis

    Professor Anders Olof Larsson

  27. Identification of Gut Microbiome Signatures and Metabolites Associated With Albuminuria in Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2025, Endocrine Society

    Professor Anders Olof Larsson

  28. Recent decline in patient serum folate test levels using Roche Diagnostics Folate III assay

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2025, De Gruyter

    Professor Anders Olof Larsson

  29. Significant Interplay Between Lipids, Cytokines, Chemokines, Growth Factors, and Blood Cells in an Outpatient Cohort

    Article • International Journal of Molecular Sciences, August 2025, MDPI AG

    Professor Anders Olof Larsson

  30. Long time monitoring of serum lithium results using patient median values show stable test results over a time period of more than 20 years

    Article • Clinical Biochemistry, August 2025, Elsevier

    Professor Anders Olof Larsson

  31. New Monitoring Recommendations for Digoxin During the Last Decade Are Associated With Decreased Serum Digoxin Concentrations in Patient Samples

    Article • Basic & Clinical Pharmacology & Toxicology, July 2025, Wiley

    Professor Anders Olof Larsson

  32. Calprotectin as a Biomarker for Infectious Diseases: A Comparative Review with Conventional Inflammatory Markers

    Article • International Journal of Molecular Sciences, July 2025, MDPI AG

    Professor Anders Olof Larsson

  33. Patient medians for NT-proBNP from six Swedish counties 2011–2021

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, July 2025, Taylor & Francis

    Professor Anders Olof Larsson

  34. Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors

    Article • Journal of Interferon & Cytokine Research, July 2025, SAGE Publications

    Professor Anders Olof Larsson

  35. Selenium and Coenzyme Q10 Supplementation and Sex Differences in Cardiovascular Mortality Results from a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly People Low in Selenium

    Article • Antioxidants, June 2025, MDPI AG

    Professor Lutz Schomburg, Professor Anders Olof Larsson

  36. Comparison of total calprotectin levels with S100A8 and S100A9 subunit levels in critically ill patients

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, May 2025, Taylor & Francis

    Professor Anders Olof Larsson

  37. Causal effects of obesity on estimated glomerular filtration rate: a Mendelian randomization and image data analysis study

    Article • Clinical Kidney Journal, April 2025, Oxford University Press (OUP)

    Professor Anders Olof Larsson

  38. Significant Associations Between Blood Cell Counts and Plasma Cytokines, Chemokines, and Growth Factors

    Article • International Journal of Molecular Sciences, April 2025, MDPI AG

    Professor Anders Olof Larsson

  39. Estimation of kidney function in Graves’ disease using creatinine and cystatin C

    Article • Endocrine Connections, April 2025, Bioscientifica

    Professor Anders Olof Larsson

  40. Serum CD5L Responds Positively to Selenium and Coenzyme Q10 Supplementation with Relation to Thyroid Hormones, Mortality, and Health-Related Quality-of-Life—A Sub-Analysis of a Double-Blind Randomised Placebo-Controlled Trial in Elderly Low in Selenium

    Article • Antioxidants, March 2025, MDPI AG

    Professor Lutz Schomburg, Professor Anders Olof Larsson

  41. Avian Antibodies as Potential Therapeutic Tools

    Article • Antibodies, February 2025, MDPI AG

    Professor Anders Olof Larsson

  42. Seven blood biomarkers are associated with TGF-β and VHL-HIF signaling in patients with clear cell renal cell carcinoma

    Article • February 2025, openRxiv

    Professor Anders Olof Larsson

  43. Circulating Glutathione Peroxidase-3 in Elderly—Association with Renal Function, Cardiovascular Mortality, and Impact of Selenium and Coenzyme Q10 Supplementation

    Article • Antioxidants, December 2024, MDPI AG

    Professor Lutz Schomburg, Professor Anders Olof Larsson

  44. Calprotectin as a sepsis diagnostic marker in critical care: a retrospective observational study

    Article • December 2024, openRxiv

    Professor Anders Olof Larsson

  45. The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease

    Article • Upsala Journal of Medical Sciences, November 2024, Uppsala Medical Society

    Axel Carlsson, Professor Anders Olof Larsson

  46. Associations between plasma osteopontin, sex, and 2-year global and cardiorenal outcomes in older outpatients screened for CKD: a secondary analysis of the SCOPE study

    Article • Clinical Kidney Journal, November 2024, Oxford University Press (OUP)

    Axel Carlsson, Francesc Formiga, Professor Anders Olof Larsson

  47. HNL Dimer in plasma is a unique and useful biomarker for the monitoring of antibiotic treatment in sepsis

    Article • PLOS One, September 2024, PLOS

    Professor Anders Olof Larsson

  48. Role of NO in Disease: Good, Bad or Ugly

    Article • Biomedicines, June 2024, MDPI AG

    Professor Anders Olof Larsson

  49. The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Increased Glomerular Production or Permeability in Diabetes Mellitus?

    Article • Journal of Clinical Medicine, April 2024, MDPI AG

    Professor Anders Olof Larsson

  50. The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus

    Article • Journal of Clinical Medicine, April 2024, MDPI AG

    Professor Anders Olof Larsson

  51. Exhaled Nitric Oxide Reflects the Immune Reactions of the Airways in Early Rheumatoid Arthritis

    Article • Biomedicines, April 2024, MDPI AG

    Professor Anders Olof Larsson

  52. Orthostatic hypotension is associated with higher levels of circulating endostatin

    Article • European Heart Journal Open, April 2024, Oxford University Press (OUP)

    Professor Anders Olof Larsson

  53. Pediatric reference intervals for serum folate and cobalamin based on a European population without exposure to folic acid fortification

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, March 2024, Taylor & Francis

    Professor Anders Olof Larsson

  54. The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Function and Activity in Diabetes Mellitus

    Article • February 2024, MDPI AG

    Professor Anders Olof Larsson

  55. The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Glomerular Activity in COVID-19 and Diabetes Mellitus

    Article • February 2024, MDPI AG

    Professor Anders Olof Larsson

  56. Analysis of HbA1c using microfluidic card (Capitainer qDBS card) as a pre-step before determination of the HbA1c value with an immunological method

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2024, Taylor & Francis

    Professor Anders Olof Larsson

  57. Effects of Seven Weeks of Combined Physical Training on High-Density Lipoprotein Functionality in Overweight/Obese Subjects

    Article • Metabolites, October 2023, MDPI AG

    Professor Anders Olof Larsson

  58. Biomarkers in Pain

    Article • Biomedicines, September 2023, MDPI AG

    Professor Anders Olof Larsson

  59. The C-reactive protein Albumin ratio was not consistently associated with cardiovascular and all-cause mortality in two community-based cohorts of 70-year-olds

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2023, Taylor & Francis

    Professor Anders Olof Larsson, Axel Carlsson

  60. Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients

    Article • Biomedicines, August 2023, MDPI AG

    Professor Anders Olof Larsson

  61. Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect—A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Ra...

    Article • Cells, July 2023, MDPI AG

    Professor Anders Olof Larsson

  62. Lipid Peroxidation and Antioxidative Capacity Are Unaltered in Transitional Breast Milk Exposed to Light from Women Giving Birth to Preterm Infants before 32 Weeks of Gestation

    Article • Nutrients, June 2023, MDPI AG

    Professor Anders Olof Larsson

  63. Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness

    Article • Clinical Journal of the American Society of Nephrology, May 2023, Wolters Kluwer Health

    Professor Anders Olof Larsson

  64. Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma

    Article • Upsala Journal of Medical Sciences, May 2023, Uppsala Medical Society

    Professor Anders Olof Larsson

  65. Increased levels of a subset of angiogenesis-related plasma proteins in essential thrombocythemia

    Article • Upsala Journal of Medical Sciences, March 2023, Uppsala Medical Society

    Professor Anders Olof Larsson

  66. Increased SIRT1 Concentration Following Four Years of Selenium and Q10 Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up—Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial

    Article • Antioxidants, March 2023, MDPI AG

    Professor Anders Olof Larsson

  67. Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study

    Article • Biomedicines, January 2023, MDPI AG

    Professor Anders Olof Larsson

  68. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment

    Article • Clinical Biochemistry, January 2023, Elsevier

    Professor Anders Olof Larsson

  69. Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Professor Anders Olof Larsson

  70. Estimated glomerular filtration rates are higher when creatinine‐based equations are compared with a cystatin C‐based equation in coronavirus disease 2019

    Article • Acta Anaesthesiologica Scandinavica, November 2022, Wiley

    Professor Anders Olof Larsson

  71. Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19

    Article • Biomedicines, October 2022, MDPI AG

    Professor Anders Olof Larsson

  72. Intravenous anti-P. aeruginosa IgY-antibodies do not decrease pulmonary bacterial concentrations in a porcine model of ventilator-associated pneumonia

    Article • Innate Immunity, October 2022, SAGE Publications

    Professor Anders Olof Larsson

  73. Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy

    Article • Journal of Feline Medicine and Surgery, September 2022, SAGE Publications

    Professor Anders Olof Larsson

  74. Selenium and Coenzyme Q10 Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality—Sub-Study of a Randomized Clinical Trial

    Article • Nutrients, August 2022, MDPI AG

    Professor Anders Olof Larsson

  75. Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved?

    Article • Human Vaccines & Immunotherapeutics, June 2022, Taylor & Francis

    Professor Anders Olof Larsson

  76. Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients

    Article • Journal of Clinical Medicine, June 2022, MDPI AG

    Professor Anders Olof Larsson

  77. Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients

    Article • Biomedicines, June 2022, MDPI AG

    Professor Anders Olof Larsson

  78. Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

    Article • Osteoporosis International, May 2022, Springer Science + Business Media

    Professor Anders Olof Larsson

  79. Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment

    Article • Scientific Reports, April 2022, Springer Science + Business Media

    Professor Anders Olof Larsson

  80. Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury

    Article • Biomedicines, April 2022, MDPI AG

    Professor Anders Olof Larsson

  81. Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis

    Article • Biomedicines, March 2022, MDPI AG

    Professor Anders Olof Larsson

  82. Decreased Concentration of Fibroblast Growth Factor 23 (FGF-23) as a Result of Supplementation with Selenium and Coenzyme Q10 in an Elderly Swedish Population: A Sub-Analysis

    Article • Cells, February 2022, MDPI AG

    Professor Anders Olof Larsson

  83. Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction

    Article • Biomedicines, January 2022, MDPI AG

    Professor Anders Olof Larsson

  84. Early kinetics of calprotectin in plasma following inguinal hernia surgery

    Article • Innate Immunity, January 2022, SAGE Publications

    Professor Anders Olof Larsson

  85. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study

    Article • Cytokine, January 2022, Elsevier

    Professor Anders Olof Larsson

  86. Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

    Article • Cancers, December 2021, MDPI AG

    Professor Anders Olof Larsson

  87. Plasma Leptin Is Increased in Intensive Care Patients with COVID-19—An Investigation Performed in the PronMed-Cohort

    Article • Biomedicines, December 2021, MDPI AG

    Professor Anders Olof Larsson

  88. Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma

    Article • Acta Haematologica, November 2021, Karger Publishers

    Professor Anders Olof Larsson

  89. A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients

    Article • Biomedicines, November 2021, MDPI AG

    Professor Anders Olof Larsson

  90. Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure

    Article • Biomarkers in Medicine, November 2021, Future Medicine

    Professor Anders Olof Larsson

  91. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis

    Article • Blood Purification, September 2021, Karger Publishers

    Professor Anders Olof Larsson

  92. Plasma calprotectin in the emergency department: a potential clinical biomarker for patients with infectious diseases

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, September 2021, Taylor & Francis

    Professor Anders Olof Larsson

  93. The association between BMI and 90-day mortality in patients with and without diabetes seeking care at the emergency department

    Article • Upsala Journal of Medical Sciences, September 2021, Uppsala Medical Society

    Axel Carlsson, Professor Anders Olof Larsson

  94. Hepatocyte growth factor, colony-stimulating factor 1, CD40, and 11 other inflammation-related proteins are associated with pain in diabetic neuropathy: exploration and replication serum data from the Pain in Neuropathy Study

    Article • Pain, August 2021, Wolters Kluwer Health

    Professor Anders Olof Larsson

  95. High molecular weight hyaluronan – a potential adjuvant to fluid resuscitation in porcine abdominal sepsis

    Article • August 2021, Cold Spring Harbor Laboratory Press

    Professor Anders Olof Larsson

  96. Strong Associations Between Early Tubular Damage and Urinary Cytokine, Chemokine, and Growth Factor Levels in Elderly Males and Females

    Article • Journal of Interferon & Cytokine Research, August 2021, Mary Ann Liebert Inc

    Professor Anders Olof Larsson

  97. Strong Associations between Plasma Osteopontin and Several Inflammatory Chemokines, Cytokines, and Growth Factors

    Article • Biomedicines, July 2021, MDPI AG

    Professor Anders Olof Larsson

  98. The Aging Kidney—As Influenced by Heavy Metal Exposure and Selenium Supplementation

    Article • Biomolecules, July 2021, MDPI AG

    Professor Anders Olof Larsson, Professor Guido Crisponi

  99. Dietary Supplementation with Selenium and Coenzyme Q10 Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population

    Article • Nutrients, April 2021, MDPI AG

    Professor Anders Olof Larsson

  100. Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans

    Article • Biomolecules, March 2021, MDPI AG

    Professor Anders Olof Larsson

  101. Bronchially instilled IgY‐antibodies did not decrease pulmonary p. aeruginosa concentration in experimental porcine pneumonia

    Article • Acta Anaesthesiologica Scandinavica, February 2021, Wiley

    Professor Anders Olof Larsson

  102. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients

    Article • Cytokine, February 2021, Elsevier

    Professor Anders Olof Larsson

  103. Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Professor Anders Olof Larsson

  104. Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial

    Article • Nutrients, December 2020, MDPI AG

    Professor Anders Olof Larsson

  105. The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis

    Article • December 2020, Karger Publishers

    Professor Anders Olof Larsson

  106. COVID‐19 patients in intensive care develop predominantly oliguric acute kidney injury

    Article • Acta Anaesthesiologica Scandinavica, November 2020, Wiley

    Professor Anders Olof Larsson

  107. Prevalence and impact of chronic dysglycemia in intensive care unit patients—A retrospective cohort study

    Article • Acta Anaesthesiologica Scandinavica, September 2020, Wiley

    Professor Anders Olof Larsson

  108. Study for Improving Maternal Pregnancy And Child ouTcomes (IMPACT): a study protocol for a Swedish prospective multicentre cohort study

    Article • BMJ Open, September 2020, BMJ

    Professor Anders Olof Larsson

  109. Long-term whole-grain rye and wheat consumption and their associations with selected biomarkers of inflammation, endothelial function, and cardiovascular disease

    Article • European Journal of Clinical Nutrition, August 2020, Springer Science + Business Media

    Professor Anders Olof Larsson

  110. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia

    Article • Growth Factors, July 2020, Taylor & Francis

    Professor Anders Olof Larsson

  111. Upregulation of circulating inflammatory biomarkers under the influence of periodontal disease in rheumatoid arthritis patients

    Article • Cytokine, July 2020, Elsevier

    Professor Anders Olof Larsson

  112. Falsely Elevated Thyroid-Stimulating Hormone Results due to Interference by M-Component of IgG-Lambda Type

    Article • Case Reports in Oncology, June 2020, Karger Publishers

    Professor Anders Olof Larsson

  113. Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study

    Article • Journal of Clinical Medicine, January 2020, MDPI AG

    Axel Carlsson, Professor Anders Olof Larsson

  114. Association of Glycated Proteins with Inflammatory Proteins and Periodontal Disease Parameters

    Article • Journal of Diabetes Research, January 2020, Hindawi Publishing Corporation

    Professor Anders Olof Larsson

  115. Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument

    Article • BMC Family Practice, June 2019, Springer Science + Business Media

    Professor Anders Olof Larsson

  116. The time course of calprotectin liberation from human neutrophil granulocytes after Escherichia coli and endotoxin challenge

    Article • Innate Immunity, May 2019, SAGE Publications

    Professor Anders Olof Larsson

  117. Accuracy of determination of the glomerular filtration marker iohexol by European laboratories as monitored by external quality assessment

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2019, De Gruyter

    Professor Anders Olof Larsson

  118. Hyaluronan concentration and molecular mass in psoriatic arthritis: biomarkers of disease severity, resistance to treatment, and outcome

    Article • Scandinavian Journal of Rheumatology, April 2019, Taylor & Francis

    Professor Anders Olof Larsson

  119. Multivariable models using administrative data and biomarkers to adjust for case mix in the ICU

    Article • Acta Anaesthesiologica Scandinavica, February 2019, Wiley

    Professor Anders Olof Larsson

  120. Age- and sex-specific reference values for non-HDL cholesterol and remnant cholesterol derived from the Nordic Reference Interval Project (NORIP)

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2019, Taylor & Francis

    Professor Anders Olof Larsson, Maria Eriksson Svensson

  121. Second Trimester Maternal Leptin Levels Are Associated with Body Mass Index and Gestational Weight Gain but not Birth Weight of the Infant

    Article • Hormone Research in Paediatrics, January 2019, Karger Publishers

    Professor Anders Olof Larsson

  122. Rapid testing of red blood cells, white blood cells and platelets in intensive care patients using the HemoScreen™ point-of-care analyzer

    Article • Platelets, December 2018, Taylor & Francis

    Professor Anders Olof Larsson

  123. The association between circulating endostatin levels and incident myocardial infarction

    Article • Scandinavian Cardiovascular Journal, November 2018, Taylor & Francis

    Professor Anders Olof Larsson, Axel Carlsson

  124. The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease—results from the SUPRIM-trial

    Article • Upsala Journal of Medical Sciences, August 2018, Taylor & Francis

    Professor Anders Olof Larsson

  125. Changes in markers of liver function in relation to changes in perfluoroalkyl substances - A longitudinal study

    Article • Environment International, August 2018, Elsevier

    Professor Anders Olof Larsson

  126. The association between circulating endostatin and a disturbed circadian blood pressure pattern in patients with type 2 diabetes

    Article • Blood Pressure, February 2018, Taylor & Francis

    Professor Anders Olof Larsson, Axel Carlsson

  127. Assessment of plasma endostatin to predict acute kidney injury in critically ill patients

    Article • Acta Anaesthesiologica Scandinavica, August 2017, Wiley

    Professor Anders Olof Larsson, Max Bell

  128. Serum Pentraxin 3 is associated with signs of arterial alteration in women with preeclampsia

    Article • International Journal of Cardiology, August 2017, Elsevier

    Professor Anders Olof Larsson

  129. Analytically Sensitive Protein Detection in Microtiter Plates by Proximity Ligation with Rolling Circle Amplification

    Article • Clinical Chemistry, June 2017, AACC

    Professor Anders Olof Larsson, Qiujin Shen

  130. Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice

    Article • OncoImmunology, April 2017, Taylor & Francis

    Professor Anders Olof Larsson

  131. The HemoCue WBC DIFF system could be used for leucocyte and neutrophil counts but not for full differential counts

    Article • Acta Paediatrica, March 2017, Wiley

    Professor Anders Olof Larsson

  132. Seasonal variations of urate in a Swedish adult population

    Article • Clinical Rheumatology, March 2017, Springer Science + Business Media

    Professor Anders Olof Larsson

  133. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma

    Article • Journal of Pain Research, March 2017, Dove Medical Press

    Professor Anders Olof Larsson, Emmanuel Bäckryd

  134. Urinary Osteopontin Predicts Incident Chronic Kidney Disease, while Plasma Osteopontin Predicts Cardiovascular Death in Elderly Men

    Article • Cardiorenal Medicine, January 2017, Karger Publishers

    Axel Carlsson, Professor Anders Olof Larsson

  135. Reference values for 34 frequently used laboratory tests in 80-year-old men and women

    Article • Maturitas, October 2016, Elsevier

    Professor Anders Olof Larsson

  136. Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community

    Article • Clinical Chemistry, January 2016, AACC

    Dr Kai M. Eggers, Professor Anders Olof Larsson, Professor Per Venge

  137. High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing Hemodialysis

    Article • Cardiorenal Medicine, January 2015, Karger Publishers

    Axel Carlsson, Professor Anders Olof Larsson

  138. Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis

    Article • Blood Purification, January 2015, Karger Publishers

    Axel Carlsson, Professor Anders Olof Larsson

  139. Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals

    Article • Cardiorenal Medicine, January 2015, Karger Publishers

    Axel Carlsson, Professor Anders Olof Larsson

  140. Comparison between Cystatin C- and Creatinine-Estimated Glomerular Filtration Rate in Cardiology Patients

    Article • Cardiorenal Medicine, January 2015, Karger Publishers

    Professor Anders Olof Larsson

  141. Urinary Kidney Injury Molecule-1 and the Risk of Cardiovascular Mortality in Elderly Men

    Article • Clinical Journal of the American Society of Nephrology, June 2014, American Society of Nephrology

    Dr Johan Ärnlöv, Professor Anders Olof Larsson, Johan Sundström, Axel Carlsson

  142. Endostatin Level is Associated with Kidney Injury in the Elderly: Findings from Two Community-Based Cohorts

    Article • American Journal of Nephrology, January 2014, Karger Publishers

    Axel Carlsson, Professor Anders Olof Larsson

  143. Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology

    Article • Clinical Journal of the American Society of Nephrology, January 2013, American Society of Nephrology

    Dr Johan Ärnlöv, Professor Anders Olof Larsson, Johan Sundström, Axel Carlsson

  144. Bell’s Palsy: An Immune Complex Disease

    Article • ORL, January 2010, Karger Publishers

    Professor Anders Olof Larsson

  145. ERRONEOUS RESULTS DUE TO BLOOD SAMPLING FROM A PERMANENT INTRAVENOUS PORT

    Article • Pediatric Hematology and Oncology, January 1999, Taylor & Francis

    Professor Anders Olof Larsson